Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.73
(3.9%)
CNY 3.73
(3.9%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.34 Billion CNY | -221.96% |
| 2022 | 948.24 Million CNY | 268.03% |
| 2021 | 257.65 Million CNY | -87.04% |
| 2020 | 1.98 Billion CNY | 169.55% |
| 2019 | 737.56 Million CNY | -6.54% |
| 2018 | 789.15 Million CNY | -14.64% |
| 2017 | 924.49 Million CNY | 6.12% |
| 2016 | 871.17 Million CNY | 15.76% |
| 2015 | 752.58 Million CNY | 11.38% |
| 2014 | 675.66 Million CNY | 47.28% |
| 2013 | 458.75 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -50.24 Million CNY | 92.38% |
| 2024 Q3 | 172.39 Million CNY | 28.65% |
| 2024 Q2 | 138.69 Million CNY | 376.06% |
| 2023 Q4 | -659.14 Million CNY | -275.74% |
| 2023 FY | -1.15 Billion CNY | -221.96% |
| 2023 Q1 | 99.78 Million CNY | -77.47% |
| 2023 Q2 | -257.71 Million CNY | -358.27% |
| 2023 Q3 | -175.42 Million CNY | 31.93% |
| 2022 Q1 | -80.79 Million CNY | 79.27% |
| 2022 FY | 948.24 Million CNY | 268.03% |
| 2022 Q3 | 594.93 Million CNY | 6885.16% |
| 2022 Q4 | 442.86 Million CNY | -25.56% |
| 2022 Q2 | -8.76 Million CNY | 89.15% |
| 2021 Q3 | -119.94 Million CNY | -184.94% |
| 2021 Q4 | -389.74 Million CNY | -224.93% |
| 2021 Q1 | 626.13 Million CNY | 8.8% |
| 2021 Q2 | 141.2 Million CNY | -77.45% |
| 2021 FY | 257.65 Million CNY | -87.04% |
| 2020 Q4 | 575.51 Million CNY | 12.72% |
| 2020 Q2 | 480.97 Million CNY | 14.24% |
| 2020 FY | 1.98 Billion CNY | 169.55% |
| 2020 Q1 | 421.01 Million CNY | 118.68% |
| 2020 Q3 | 510.59 Million CNY | 6.16% |
| 2019 FY | 737.56 Million CNY | -6.54% |
| 2019 Q4 | 192.52 Million CNY | 8.73% |
| 2019 Q3 | 177.06 Million CNY | 3.67% |
| 2019 Q2 | 170.79 Million CNY | -13.38% |
| 2019 Q1 | 197.18 Million CNY | -1.89% |
| 2018 Q2 | 170.02 Million CNY | -18.26% |
| 2018 Q4 | 200.99 Million CNY | -4.35% |
| 2018 Q3 | 210.12 Million CNY | 23.58% |
| 2018 FY | 789.15 Million CNY | -14.64% |
| 2018 Q1 | 208.01 Million CNY | -13.64% |
| 2017 FY | 924.49 Million CNY | 6.12% |
| 2017 Q1 | 223.74 Million CNY | -2.09% |
| 2017 Q2 | 231.48 Million CNY | 3.46% |
| 2017 Q3 | 228.39 Million CNY | -1.33% |
| 2017 Q4 | 240.86 Million CNY | 5.46% |
| 2016 Q4 | 228.51 Million CNY | 9.51% |
| 2016 FY | 871.17 Million CNY | 15.76% |
| 2016 Q3 | 208.66 Million CNY | 0.0% |
| 2015 FY | 752.58 Million CNY | 11.38% |
| 2014 FY | 675.66 Million CNY | 47.28% |
| 2013 FY | 458.75 Million CNY | 0.0% |